Pages that link to "Q70466614"
Jump to navigation
Jump to search
The following pages link to Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists (Q70466614):
Displaying 50 items.
- TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. (Q24314730) (← links)
- Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family (Q24315643) (← links)
- Separation of mAbs molecular variants by analytical hydrophobic interaction chromatography HPLC: overview and applications (Q26824543) (← links)
- Selective Allosteric Inhibition of MMP9 Is Efficacious in Preclinical Models of Ulcerative Colitis and Colorectal Cancer (Q27306938) (← links)
- Gene expression-based classifiers identify Staphylococcus aureus infection in mice and humans (Q27339671) (← links)
- Inflammation induced loss of skeletal muscle (Q28083759) (← links)
- Tumor necrosis factor-alpha induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons (Q28189772) (← links)
- An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management (Q28308246) (← links)
- Inflammatory cascades driven by tumor necrosis factor-alpha play a major role in the progression of acute liver failure and its neurological complications (Q28485217) (← links)
- Efficient production of sTNFRII-gAD fusion protein in large quantity by use of the modified CHO-S cell expression system (Q28544073) (← links)
- Increased sensitivity of injured and adjacent uninjured rat primary sensory neurons to exogenous tumor necrosis factor-alpha after spinal nerve ligation (Q28571634) (← links)
- Linker length matters, fynomer-Fc fusion with an optimized linker displaying picomolar IL-17A inhibition potency (Q30009438) (← links)
- Immune system of the inner ear as a novel therapeutic target for sensorineural hearing loss (Q30430796) (← links)
- Effect of soluble P55 tumour-necrosis factor binding fusion protein on the local Shwartzman and Arthus reactions (Q30443950) (← links)
- A phage-displayed mimotope inhibits tumour necrosis factor-alpha-induced cytotoxicity more effectively than the free mimotope (Q30629470) (← links)
- Parasite-dependent expansion of TNF receptor II-positive regulatory T cells with enhanced suppressive activity in adults with severe malaria (Q33434467) (← links)
- The protective antibodies induced by a novel epitope of human TNF-alpha could suppress the development of collagen-induced arthritis (Q33527432) (← links)
- A variant of TNFR2-Fc fusion protein exhibits improved efficacy in treating experimental rheumatoid arthritis (Q33530087) (← links)
- Disease-inducible transgene expression from a recombinant adeno-associated virus vector in a rat arthritis model (Q33645324) (← links)
- Higher C-reactive protein and soluble tumor necrosis factor receptor levels are associated with poor physical function and disability: a cross-sectional analysis of a cohort of late middle-aged African Americans (Q33654592) (← links)
- Etanercept: a review of its use in rheumatoid arthritis (Q33684274) (← links)
- ADAM-17: the enzyme that does it all. (Q33737421) (← links)
- Adverse housing and neighborhood conditions and inflammatory markers among middle-aged African Americans (Q33754345) (← links)
- Etanercept: therapeutic use in patients with rheumatoid arthritis (Q33782355) (← links)
- PEGylated recombinant human soluble tumour necrosis factor receptor type I (r-Hu-sTNF-RI): novel high affinity TNF receptor designed for chronic inflammatory diseases (Q33782360) (← links)
- Involvement of tumor necrosis factor-alpha in natriuretic response to systemic infusion of nitric oxide synthase inhibitor in anesthetized mice (Q33995168) (← links)
- Treating inflammatory bowel disease by adsorptive leucocytapheresis: a desire to treat without drugs (Q34008773) (← links)
- Chronic hepatosplenomegaly in African school children: a common but neglected morbidity associated with schistosomiasis and malaria (Q34017976) (← links)
- Histopathologic insights into the mechanism of anti-non-Gal antibody-mediated pig cardiac xenograft rejection (Q34018912) (← links)
- Etanercept (Enbrel): update on therapeutic use (Q34071287) (← links)
- Tumour necrosis factor and anti-tumour necrosis factor approach to inflammatory demyelinating diseases of the central nervous system (Q34071322) (← links)
- Tumour necrosis factor in chronic heart failure: a peripheral view on pathogenesis, clinical manifestations and therapeutic implications (Q34127393) (← links)
- Development of a Nascent Galectin-1 Chimeric Molecule for Studying the Role of Leukocyte Galectin-1 Ligands and Immune Disease Modulation (Q34192497) (← links)
- Suppression of proinflammatory cytokines in monocytes by a tetravalent guanylhydrazone (Q34381322) (← links)
- Viral escape mechanisms--escapology taught by viruses (Q34434767) (← links)
- Etanercept in the treatment of plaque psoriasis (Q34620263) (← links)
- Interleukin-15:Interleukin-15 receptor scaffold for creation of multivalent targeted immune molecules (Q34626998) (← links)
- Novel lymphotoxin alpha (LTalpha) knockout mice with unperturbed tumor necrosis factor expression: reassessing LTalpha biological functions. (Q34717984) (← links)
- Etanercept in the treatment of rheumatoid arthritis (Q34764213) (← links)
- Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis (Q34991484) (← links)
- Generation and characterization of small single domain antibodies inhibiting human tumor necrosis factor receptor 1. (Q35080243) (← links)
- The development and assessment of biological treatments for children (Q35135936) (← links)
- Protection from endotoxic shock in mice by pharmacologic inhibition of phosphatidic acid (Q35201746) (← links)
- Selective modulation of lipopolysaccharide-induced death and cytokine production by various muramyl peptides (Q35378360) (← links)
- Effects of TNF-alpha neutralization on adipocytokines and skeletal muscle adiposity in the metabolic syndrome (Q35384250) (← links)
- Antiendotoxin activity of cationic peptide antimicrobial agents (Q35530704) (← links)
- Increased peripheral T cell reactivity to microbial antigens and collagen type II in rheumatoid arthritis after treatment with soluble TNFalpha receptors (Q35550051) (← links)
- Interactions between IL-32 and tumor necrosis factor alpha contribute to the exacerbation of immune-inflammatory diseases (Q35630027) (← links)
- Etanercept and sulfasalazine, alone and combined, in patients with active rheumatoid arthritis despite receiving sulfasalazine: a double-blind comparison (Q35637985) (← links)
- Etanercept 50 mg once weekly is as effective as 25 mg twice weekly in patients with ankylosing spondylitis (Q35638509) (← links)